Brief · Use case · Public Affairs
FDA Guidance Horizon Scan.
LiveScanList the draft and final FDA guidance documents on a product class, each with its date and status, and keep guidance apart from rules.
FDA Guidance Horizon Scan is a ready-made use case for Public Affairs. It ships under the Scan template.
For regulatory and public affairs leads tracking guidance. You get the boundary, each draft and final document with its date and the status its notice states, and what stands out. Guidance is not a rule, and the scan says so. Entries are cited to FDA or marked as gaps.
Add it to your library to reuse from New → From template. Edit the saved copy in your library on the service form.
The decision
Which draft and final FDA guidance documents on a named product class have been issued or are open for comment, what is the status of each, and what does each cover?
Where the scan looks
Guidance is not a rule, and the scan keeps the two apart. Each document is listed once with its date and status, and the scan says where a status could not be confirmed.
| Source | What it holds | What the scan does with it |
|---|---|---|
| Draft guidance | Lists each draft with its date and the comment status its Federal Register notice states.1 | FDA’s guidance pages and the notice that announced the draft. |
| Final guidance | Lists each final guidance with its date and what it replaced.1 | FDA’s guidance pages. |
| What guidance does not do | Notes that guidance documents do not establish legally enforceable rights or responsibilities and do not legally bind the public or FDA, so a guidance is read as FDA’s current thinking and not as a rule.1 | The regulation on good guidance practices. |
What the scan does
A draft is not final. After drafting, FDA announces a Level 1 draft in a Federal Register notice, posts it and invites comment, then reviews the comments and prepares the final version. The scan keeps drafts and finals apart and gives the status the notice states.1
Guidance is not a rule. The scan says plainly that guidance does not bind the public or FDA, and lists notice-and-comment rulemaking separately when the field has both.1,2
Maturity as judgment. Each document is labeled Established, Emerging or Weak signal, as analyst judgment, so a draft early in comment is not read as settled practice.
Recommended length
Standard
The product class and the agency are bounded and the list is short. Standard carries the boundary, the documents and what stands out; Comprehensive adds how the scan was run and suits a standing watch.
You can pick another length on the form. The other two stay available.
Assumptions the scan checks
The scan states the assumptions its boundary and its sources rest on, and the closing section says what they leave out. Examples for this subject:
- The product class falls inside the guidance topics the scan searched.
- FDA’s guidance pages are current on the date of the scan.
- Guidance from other agencies is covered by a separate scan.
Standards, guidance and sources
Frame
The decision practice behind the memo itself is on the template page.
What gets flagged
Any guidance listed without its date and status, any draft presented as final, any comment deadline taken from outside the notice, and any term given without the document that states it and that document’s date.
What arrives
- Scope and boundary
- How the scan was run
- What is out there
- How the field divides
- What stands out
- What this does not cover
What it will not do
It does not rank or score the items it finds, and it does not recommend one. A scan lists what exists; when you need a view on it, run a Comparison or a Decision Memo on the items you choose.
It does not interpret what a guidance requires of a product and does not advise on a comment.
It does not rank or score the items. A scan says what exists; it does not say which item is preferable.
It is a snapshot of one date. It does not monitor the field after that date.
It lists what it could find in the sources it names. Items in sources it could not open are listed as not covered.
References
- [1] U.S. Code of Federal Regulations. 21 CFR 10.115: Good guidance practices (Legal Information Institute, Cornell Law School). Read. A Level 1 guidance document sets out initial interpretations or changes in interpretation or policy of more than a minor nature, or addresses complex scientific or highly controversial issues. After drafting, FDA publishes a Federal Register notice, posts the draft and invites comment, then reviews the comments and prepares the final version. Guidance documents do not establish legally enforceable rights or responsibilities and do not legally bind the public or FDA.
- [2] Legal Information Institute, Cornell Law School. Rulemaking (Wex): notice-and-comment rulemaking under the Administrative Procedure Act. Read. The page describes a notice of proposed rulemaking in the Federal Register, written comments often submitted through the public docket on Regulations.gov, and a final rule with a statement of its basis and purpose.
Links checked 12 October 2026
These are the sources the template drew on. None of their authors or issuers has reviewed it.
About the Brief service
A Brief is a written answer from one specialist, at the depth you asked for. It arrives with its sources, and it closes by saying plainly what would change the conclusion. Nothing is hidden behind a summary, and anything the expert could not source is marked as a gap rather than filled in.
To edit a saved template, open New → Brief → From template, or the library rail on the service form.